医学
放射外科
指南
梅德林
前庭神经鞘瘤
人口
循证医学
系统回顾
纳入和排除标准
听神经瘤
放射治疗
外科
放射科
前庭系统
病理
替代医学
环境卫生
政治学
法学
作者
Isabelle M. Germano,Sheryl Green,Eric J. Lehrer,Mateo Ziu,Jeffrey J. Olson
出处
期刊:Neurosurgery
[Lippincott Williams & Wilkins]
日期:2025-06-05
标识
DOI:10.1227/neu.0000000000003416
摘要
BACKGROUND: Stereotactic radiosurgery (SRS) is an established modality for treatment of adult patients with vestibular schwannomas (VS). The aim of this work was to provide an updated literature review on this topic. OBJECTIVE: To review the literature published since the last guideline on this topic. METHODS: OVID MEDLINE and Embase were searched for the period January 1, 2015, to May 20, 2022, using search terms and search strategies to identify pertinent abstracts. These were then screened using published exclusion/inclusion criteria to identify full-text review articles. Evidence tables were constructed using data derived from full-text reviews and recommendations made from the evidence derived. RESULTS: From the total 1035 abstracts identified, 26 full-text articles met inclusion/exclusion criteria and were included in this update. Four new level III recommendations stemmed from this work. In adult patients with sporadic intracanalicular or <2 cm VS, SRS should not be recommended as superior to observation alone for hearing preservation. In adult patients with sporadic VS treated with SRS, cochlear dose constraint should be considered because it provides better hearing preservation than no constraint. In the same population, single fraction SRS should be recommended rather than hypofractionated SRS (>1 and ≤5 fractions) because it results in decreased cranial nerve dysfunction. Finally, adult patients with sporadic VS undergoing SRS should be informed that SRS does not result in an increased number of secondary malignancies compared with the rate expected in the overall population. CONCLUSION: Recent published literature provides new recommendations for the treatment of adult patients with VS with SRS.
科研通智能强力驱动
Strongly Powered by AbleSci AI